Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China
· Delayed Price · Currency is CNY 38.56
-0.19 (-0.49%)
At close: Mar 9, 2026
SHA:603014 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | 474.39 | 449.37 | 442.07 | 314.96 | 259.82 |
| Depreciation & Amortization | 240 | 240 | 238.25 | 238.3 | 201.41 |
| Other Amortization | 5.51 | 5.51 | 7.03 | 6.61 | 5.33 |
| Loss (Gain) From Sale of Assets | -0.2 | -0.2 | -0.09 | 0.01 | -0.01 |
| Asset Writedown & Restructuring Costs | 11.06 | 11.06 | 6.2 | 5.61 | 5.62 |
| Loss (Gain) From Sale of Investments | -0.22 | -0.22 | -0.11 | - | -15.86 |
| Stock-Based Compensation | 10.97 | 10.97 | 27.11 | 52.96 | 71.02 |
| Provision & Write-off of Bad Debts | 38.71 | 38.71 | 19.3 | 25.37 | -0.03 |
| Other Operating Activities | 128.05 | -35.12 | -25.78 | -9.88 | 46.71 |
| Change in Accounts Receivable | -120.61 | -120.61 | 27.5 | -188.05 | -222.91 |
| Change in Inventory | 142.77 | 142.77 | -262.4 | -117.45 | -101.94 |
| Change in Accounts Payable | -170.24 | -170.24 | -196.98 | 413.24 | 257.92 |
| Operating Cash Flow | 760.49 | 572.3 | 288.14 | 727.33 | 504.89 |
| Operating Cash Flow Growth | 163.93% | 98.62% | -60.38% | 44.06% | - |
| Capital Expenditures | -161.29 | -179.3 | -232.81 | -279.8 | -401.25 |
| Sale of Property, Plant & Equipment | 3.78 | 3.88 | 6.87 | 8.1 | 16.88 |
| Investment in Securities | -790 | -259.91 | 37.54 | 10.2 | 5.58 |
| Other Investing Activities | 64.22 | 56 | 0.89 | 19.47 | 0.15 |
| Investing Cash Flow | -883.29 | -379.34 | -187.51 | -242.03 | -378.63 |
| Short-Term Debt Issued | - | 3.18 | 6.64 | 480.07 | 677.95 |
| Total Debt Issued | 3.18 | 3.18 | 6.64 | 480.07 | 677.95 |
| Short-Term Debt Repaid | - | - | -41.8 | -1,238 | -765.02 |
| Long-Term Debt Repaid | - | -8.26 | -7.48 | -82.69 | - |
| Total Debt Repaid | -8.26 | -8.26 | -49.28 | -1,321 | -765.02 |
| Net Debt Issued (Repaid) | -5.08 | -5.08 | -42.63 | -840.82 | -87.08 |
| Issuance of Common Stock | 1,216 | - | - | 624.21 | - |
| Common Dividends Paid | - | - | -0.49 | -18.84 | -42.71 |
| Other Financing Activities | -100.39 | -10.36 | -4.23 | 13.33 | -116.19 |
| Financing Cash Flow | 1,110 | -15.44 | -47.35 | -222.11 | -245.97 |
| Foreign Exchange Rate Adjustments | 1.72 | -0.51 | 0.84 | 3.26 | -0.9 |
| Net Cash Flow | 989.38 | 177.02 | 54.11 | 266.45 | -120.61 |
| Free Cash Flow | 599.2 | 393 | 55.33 | 447.53 | 103.64 |
| Free Cash Flow Growth | 982.95% | 610.28% | -87.64% | 331.80% | - |
| Free Cash Flow Margin | 16.21% | 10.90% | 1.57% | 13.06% | 3.56% |
| Free Cash Flow Per Share | 1.53 | 1.06 | 0.15 | 1.23 | 0.29 |
| Cash Income Tax Paid | 333.32 | 343.06 | 302.29 | 203.49 | 265.76 |
| Levered Free Cash Flow | - | 354.35 | 95.24 | 266.53 | - |
| Unlevered Free Cash Flow | - | 354.72 | 95.77 | 277.99 | - |
| Change in Working Capital | -147.78 | -147.78 | -425.84 | 93.38 | -69.13 |
Source: S&P Capital IQ. Standard template. Financial Sources.